AWM Investment Company »

Avita Therapeutics shares owned by AWM Investment Company

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by AWM Investment Company from 13F filings

Historical chart of AWM Investment Company investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by AWM Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by AWM Investment Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8M 497k 13.72

More positions owned by AWM Investment Company

Destination XL Group common (DXLG)
Aspen Aerogels common (ASPN)
Aehr Test Systems common (AEHR)
Impinj common (PI)
ADMA Biologics common (ADMA)
American Superconductor Corpor common (AMSC)
Infusystem Holdings common (INFU)
Everspin Technology common (MRAM)
Repligen Corporation common (RGEN)
Kopin Corporation common (KOPN)
Leonardo DRS common (DRS)
Arbe Robotics common (ARBE)
Ooma common (OOMA)
Universal Technical Institute common (UTI)
Aerovironment common (AVAV)

View all positions for AWM Investment Company

Top funds holding Avita Therapeutics

Vanguard Group
AWM Investment Company
Bank of New York Mellon
Dimensional Fund Advisors
Soleus Capital Management
1492 Capital Management
Charles Schwab Investment Management
AQR Capital Management
D. E. Shaw & Co
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Two Sigma Advisers
Bank of America Corporation
Barclays
Rhumbline Advisers
Wellington Management Company

View all funds holding Avita Therapeutics